TSS:Hg 56092.1

Basic information about the TSS

---

TSS ID: hg_56092.1 Species: human Chr: chr5		Start: 34929572 End: 34929684 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000342382.8 ENST00000382021.2 NM_194283 NM_001012339 uc003jjc.4 uc003jjb.3 BC065745 AY177688 AY258422 Distance: 0 GeneID: 134218 HGNC/MGI_ID: HGNC:27030 UniProt_ID: Q5F1R6

Gene_name: DnaJ heat shock protein family (Hsp40) member C21 Gene_symbol: DNAJC21 Gene_synonyms: DNAJA5 GS3 JJJ1 Gene_source: HGNC:27030

TATA-Box annotation

---

Distance to TSS:	35
Nearest PromoterID:	NM_001012339
Entrez ID:	134218
Nearest Unigene:	Hs.131887
Nearest Refseq:	NM_194283
Nearest Ensembl:	ENSG00000168724
Gene Name:	DnaJ heat shock protein family (Hsp40) member C21
Gene Alias:	BMFS3
Gene Description:	DnaJ heat shock protein family (Hsp40) member C21
Gene Type:	protein-coding
CpG%:	0.165
GC%:	0.79602
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DNAJC21 p2@DNAJC21 p3@DNAJC21 p4@DNAJC21
Sample		p1@DNAJC21	p2@DNAJC21	p3@DNAJC21	p4@DNAJC21
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.19	12.27	1.95	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.81	10.72	2.43	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.04	7.91	1.74	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.11	10.40	1.46	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.09	10.12	1.35	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.46	9.50	2.91	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	47.28	16.78	1.09	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	43.12	13.81	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.54	11.54	0.64	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	45.21	19.71	1.74	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	45.68	16.17	2.43	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	50.82	24.80	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.34	2.90	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.37	1.65	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.44	2.85	1.10	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.34	0.25	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.52	1.53	0.87	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	1.69	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	1.07	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.04	3.01	1.05	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	1.74	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.33	1.38	1.04	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.05	2.84	1.42	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.77	1.70	0.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.06	3.61	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.24	3.17	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	22.53	2.75	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.45	3.30	0.94	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.05	3.23	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.92	2.71	0.90	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.38	2.30	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.44	3.13	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.51	2.74	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.35	2.64	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.28	1.87	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.01	2.68	0.57	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.94	2.25	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.48	2.62	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.26	2.97	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	22.57	3.60	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.00	2.35	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.79	2.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	20.25	3.37	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.80	3.32	1.22	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.28	2.81	1.41	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.43	3.95	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	26.63	3.60	0.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.33	5.96	0.60	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.77	5.03	2.15	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.62	4.25	1.42	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.17	2.87	2.25	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.68	4.00	1.11	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	0.00	55.97	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	2.13	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.59	2.32	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	3.36	12.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	1.84	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.61	2.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.34	4.18	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	2.83	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	3.98	2.39	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.12	1.02	2.72	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.05	2.27	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	4.26	1.77	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	16.16	64.66	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	126.36	0.00	39.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	1.95	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.35	3.97	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.73	1.41	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.60	2.32	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.16	2.17	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.24	2.75	1.53	0.31
Adipocyte - breast, donor1	11376-118A8	22.81	2.69	3.80	0.63
Adipocyte - breast, donor2	11327-117E4	21.18	2.41	3.05	1.44
Adipocyte - omental, donor1	11473-119C6	24.94	5.85	2.67	0.76
Adipocyte - omental, donor2	11474-119C7	29.90	1.49	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	18.42	1.00	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	5.74	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.87	4.52	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	14.94	2.78	4.00	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	22.10	2.74	1.56	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	16.47	2.32	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	20.63	1.67	1.12	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	34.09	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.93	3.70	2.25	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	22.27	0.97	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	2.13	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	18.36	1.67	1.67	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	16.64	0.83	0.83	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	20.85	1.76	1.51	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	1.96	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	14.61	1.83	1.52	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	5.52	1.33	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.41	3.60	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	1.64	0.62	0.41
Anulus Pulposus Cell, donor1	11248-116E6	14.99	2.52	2.86	0.23
Anulus Pulposus Cell, donor2	11463-119B5	12.00	3.43	1.47	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	3.15	4.04	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	1.30	3.04	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	2.14	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.13	1.49	4.18	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	2.53	7.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	1.32	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.57	0.97	2.60	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	18.93	1.94	5.83	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	0.00	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.82	2.64	2.64	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	2.18	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	1.25	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.79	3.62	3.79	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	1.36	9.55	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.09	2.11	2.87	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	1.61	2.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.87	2.65	3.21	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.71	0.53	4.81	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	2.93	3.90	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.93	2.32	2.65	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	3.60	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	17.32	1.37	2.57	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.53	1.46	3.40	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	2.66	1.90	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	3.63	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	2.28	4.56	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.89	2.14	3.85	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.23	2.84	0.77	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	2.35	6.10	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.33	3.22	3.22	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	0.00	2.85	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	3.51	4.68	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.06	3.91	3.61	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	1.19	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.33	3.56	2.54	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.05	2.80	5.09	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	1.27	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	2.16	2.16	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.45	2.54	3.81	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.79	0.29	2.03	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	0.94	2.83	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.63	2.37	2.71	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.30	2.14	3.43	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	20.46	1.80	1.20	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	2.19	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.17	2.53	2.99	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.85	2.29	3.31	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.96	0.62	2.89	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.52	3.06	1.22	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.12	4.78	4.30	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.63	2.00	2.88	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	1.11	3.88	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.59	2.65	2.91	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.26	2.18	3.63	1.45
Astrocyte - cerebellum, donor1	11500-119F6	10.07	1.23	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	11.64	1.37	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.99	1.68	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	27.89	5.93	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	35.10	5.18	2.59	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	30.73	4.33	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	59.29	9.06	2.52	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	59.51	9.52	3.26	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.33	10.24	3.07	0.57
Basophils, donor1	12241-129G9	18.57	4.45	0.26	1.83
Basophils, donor2	12242-129H1	37.88	4.69	2.16	0.00
Basophils, donor3	12243-129H2	24.70	3.67	1.32	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	7.55	1.08	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	2.51	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	9.57	1.25	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	10.13	1.61	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	23.21	4.68	4.32	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	60.80	6.80	1.96	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	51.94	8.38	3.73	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	46.37	5.76	1.60	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	10.34	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	22.54	6.20	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	44.17	9.65	1.48	2.78
CD14+ Monocytes, donor3	11381-118B4	39.96	5.71	1.32	2.85
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	29.15	2.26	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.54	3.41	3.03	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	2.30	2.30	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	23.27	2.46	1.45	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	22.93	3.02	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	27.95	2.61	0.95	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.58	2.01	0.84	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	17.39	3.59	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.34	3.22	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.31	1.96	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.18	1.78	1.25	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	15.45	2.39	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.28	3.28	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.78	3.70	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	5.55	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.32	2.68	1.04	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.36	1.80	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.49	2.50	1.04	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.38	2.52	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	17.42	1.36	0.90	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	2.18	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.56	3.50	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	18.32	2.09	0.70	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	26.09	3.37	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.19	1.29	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	1.76	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.11	3.51	0.44	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.39	1.92	1.22	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	1.49	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	16.60	4.31	1.29	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	1.64	1.23	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.59	2.32	0.00	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.90	2.09	0.23	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	27.46	3.49	3.05	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	25.18	4.39	2.77	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	23.61	4.77	3.25	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	47.18	4.83	1.71	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	27.94	4.37	1.57	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	45.04	5.80	3.79	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	22.71	3.57	1.79	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	24.37	3.07	2.63	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	23.16	3.58	3.58	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	0.00	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.97	3.39	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	6.21	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	39.44	2.67	2.67	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	45.03	3.22	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	2.11	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.81	3.14	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	54.25	3.29	1.64	4.11
CD19+ B Cells, donor2	11624-122B4	43.53	8.71	2.90	3.63
CD19+ B Cells, donor3	11705-123B4	76.23	4.54	3.03	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	49.70	8.89	3.64	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	43.54	8.79	2.40	0.80
CD34+ Progenitors, donor1	11545-120B6	40.16	3.01	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	40.45	5.06	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	1.88	1.88	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	41.26	3.83	2.03	0.00
CD4+ T Cells, donor1	11225-116C1	102.12	8.57	6.07	2.86
CD4+ T Cells, donor2	11306-117C1	87.57	4.29	1.84	11.63
CD4+ T Cells, donor3	11382-118B5	67.40	4.88	3.05	5.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	41.09	3.32	8.93	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.84	3.82	6.74	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	46.57	3.74	7.76	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	59.74	6.64	2.84	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	50.57	2.11	2.81	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	82.41	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.35	2.31	6.79	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	43.21	2.54	3.73	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	35.47	2.74	3.87	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	46.17	5.83	4.48	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.83	4.54	4.19	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.16	3.52	7.48	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	56.92	2.95	4.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	45.71	1.66	3.32	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	42.10	1.67	3.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	73.97	5.17	2.18	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	70.75	5.36	2.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	53.80	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	61.93	3.15	5.01	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	47.44	1.52	3.25	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.65	4.20	2.52	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	47.02	3.03	2.53	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	46.36	4.77	5.63	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.50	4.36	3.92	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	50.97	4.95	4.45	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	0.92	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	0.00	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	50.68	2.49	5.82	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	53.74	3.19	5.15	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	4.62	7.70	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	48.35	3.22	4.30	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	45.70	1.38	8.31	0.00
CD8+ T Cells, donor1	11226-116C2	85.78	7.20	2.29	8.84
CD8+ T Cells, donor2	11307-117C2	72.46	6.38	5.63	10.51
CD8+ T Cells, donor3	11383-118B6	76.25	7.07	3.28	12.88
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.86	1.84	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.72	1.44	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.72	1.92	1.09	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.61	2.10	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.96	2.40	1.44	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.46	3.64	1.36	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.20	2.82	1.30	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.37	2.63	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.09	1.64	1.41	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.07	2.11	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	35.44	2.03	2.61	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.57	3.73	1.33	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.02	3.94	0.44	6.57
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.97	2.73	0.00	5.92
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	34.31	2.98	1.49	8.95
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.41	3.24	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.44	0.86	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.50	1.18	0.71	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	18.06	0.95	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.45	1.85	0.62	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.21	0.64	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	31.74	2.29	3.06	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.16	3.55	2.76	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	3.03	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.97	8.83	2.41	9.64
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	41.27	5.60	4.20	13.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	47.08	8.01	1.00	16.03
Cardiac Myocyte, donor1	11525-119I4	16.45	3.66	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	18.78	0.49	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	14.94	2.10	1.05	0.11
Chondrocyte - de diff, donor1	11261-116G1	23.57	3.81	2.43	0.69
Chondrocyte - de diff, donor2	11338-117F6	12.44	2.84	2.13	0.36
Chondrocyte - de diff, donor3	11410-118E6	27.99	2.84	2.28	1.82
Chondrocyte - re diff, donor2	11339-117F7	22.38	0.90	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.98	3.64	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	29.15	5.51	2.30	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	21.59	3.63	2.99	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	26.20	4.69	1.86	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.08	9.81	1.28	0.46
Corneal Epithelial Cells, donor1	11526-119I5	4.39	1.54	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	1.02	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.70	1.98	2.64	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	25.23	1.26	2.84	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.54	1.30	1.94	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	40.31	6.15	1.02	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.87	2.61	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.07	7.26	2.90	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	10.34	0.83	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.88	1.70	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	14.55	1.18	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	8.73	1.16	1.45	0.00
Endothelial Cells - Artery, donor2	11341-117F9	18.82	2.35	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	11.57	0.18	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.95	1.99	3.10	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.25	3.04	5.48	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	26.50	1.97	3.38	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	9.21	0.30	1.78	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	13.54	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.10	0.85	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	27.21	2.00	2.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.36	3.23	2.73	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.76	2.39	1.52	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	35.42	3.79	0.85	0.37
Endothelial Cells - Vein, donor1	11267-116G7	14.79	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	12.57	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.93	1.41	0.79	0.00
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	9.90	1.65	1.65
Eosinophils, donor3	12246-129H5	24.97	14.27	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.62	0.49	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.53	3.28	2.46	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.61	1.64	1.86	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.71	2.28	2.60	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.68	3.27	2.18	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.79	3.96	3.14	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.20	3.16	2.43	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.60	1.84	1.84	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	26.24	3.32	2.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	15.42	2.72	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	12.89	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.52	0.95	0.95	0.95
Fibroblast - Cardiac, donor4	11452-119A3	28.49	6.06	5.15	0.91
Fibroblast - Cardiac, donor5	11456-119A7	23.98	2.79	1.90	0.13
Fibroblast - Cardiac, donor6	11460-119B2	24.56	2.73	1.06	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.34	1.61	1.34	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.24	0.86	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	20.30	4.38	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	28.49	6.11	5.09	1.02
Fibroblast - Dermal, donor1	11269-116G9	12.68	3.52	1.88	1.41
Fibroblast - Dermal, donor2	11346-117G5	14.62	2.36	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.97	3.87	5.44	0.97
Fibroblast - Dermal, donor4	11450-119A1	29.73	4.75	1.92	0.11
Fibroblast - Dermal, donor5	11454-119A5	37.51	2.97	1.92	0.52
Fibroblast - Dermal, donor6	11458-119A9	43.04	4.71	1.79	0.00
Fibroblast - Gingival, donor1	11237-116D4	34.15	4.79	9.37	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.56	4.45	1.83	0.79
Fibroblast - Gingival, donor2	11318-117D4	30.97	6.85	3.29	0.53
Fibroblast - Gingival, donor3	11394-118C8	39.74	5.32	4.64	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	7.27	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	30.84	4.23	3.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.21	5.14	2.49	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	34.48	3.79	2.16	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	28.23	8.47	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	40.51	4.09	1.61	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	46.09	3.27	1.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.79	5.05	1.10	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	28.32	3.52	2.05	0.44
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	7.46	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	22.79	4.01	1.06	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	16.66	3.33	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.32	0.84	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	18.67	2.84	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	35.50	6.79	4.07	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	48.69	5.76	2.58	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	60.89	7.04	8.87	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.57	1.53	1.91	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.32	2.16	0.27	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.43	3.94	0.93	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.24	2.10	1.99	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.69	3.25	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	21.74	2.77	5.14	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.46	3.37	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.54	1.95	3.73	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.61	2.76	2.56	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.25	1.81	1.81	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.31	3.67	3.13	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.01	1.52	1.52	1.27
Fibroblast - skin normal, donor1	11553-120C5	23.14	2.13	0.98	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.05	4.41	1.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	22.40	3.01	1.71	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.69	3.93	1.51	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	33.22	3.40	3.73	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.86	2.74	6.67	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.42	1.97	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.49	3.30	1.92	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	21.93	3.54	0.84	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.58	1.88	2.35	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	22.16	66.48	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	2.61	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.40	2.25	1.91	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	25.50	4.42	1.56	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	29.38	3.07	4.09	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	20.67	10.72	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	30.63	8.29	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	49.92	9.98	3.99	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.78	8.55	1.93	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.06	7.76	1.83	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.38	9.71	2.77	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	28.55	7.14	2.11	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	7.18	0.98	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	34.94	11.50	6.19	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	29.11	6.22	2.40	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	32.26	9.36	1.72	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	31.43	5.91	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	29.36	5.20	0.87	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.45	8.03	1.80	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	32.12	6.30	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.00	5.93	1.60	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.66	5.98	1.74	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.01	7.43	1.09	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	29.25	5.91	1.48	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.00	6.04	1.75	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	28.37	6.93	1.34	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.99	6.05	0.60	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	24.26	5.77	2.21	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	36.36	6.12	1.33	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.63	6.04	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.57	5.12	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.56	5.31	1.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.70	5.16	1.41	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.87	4.08	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	3.71	1.44	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.48	5.65	1.38	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.68	4.00	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.81	1.98	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.37	5.29	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.67	4.70	1.13	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.30	5.45	0.64	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.99	3.70	0.76	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	22.94	3.01	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.11	3.34	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.37	4.18	0.84	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.96	4.83	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.57	3.65	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.37	3.61	0.93	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.66	2.41	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.49	4.28	0.92	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.04	4.40	1.04	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	3.52	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.94	2.95	1.66	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.93	1.97	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	46.61	3.97	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	26.51	4.75	1.45	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	24.61	3.63	1.82	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.74	5.59	4.57	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	49.96	7.76	3.38	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	45.61	8.32	2.62	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	50.53	10.84	2.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.47	3.44	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	21.19	1.98	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.99	3.69	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	0.00	12.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	24.76	4.25	2.71	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	6.42	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	10.43	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.06	2.93	2.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	34.59	6.18	4.94	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	16.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	32.44	8.11	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.65	5.88	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	7.55	7.55	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.85	7.32	1.91	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	33.29	5.77	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	10.44	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.78	4.58	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	21.61	3.85	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	6.78	6.78	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	27.34	5.38	5.38	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.46	6.67	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.68	3.46	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.75	5.87	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.74	8.69	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.67	9.63	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	32.52	9.59	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	28.31	8.49	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	7.24	3.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	14.75	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	22.33	4.79	1.60	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	33.05	7.40	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	37.77	8.26	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	8.17	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.97	8.34	2.63	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	25.43	8.48	4.24	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	3.58	2.98	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	3.88	1.94	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	2.28	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	0.83	2.91	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	4.12	7.61	4.12
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.79	2.51	5.01	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	73.80	11.84	7.19	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	88.79	15.19	5.91	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	88.27	12.74	6.37	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	71.93	10.28	5.47	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	76.94	13.54	3.65	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	82.24	13.99	4.09	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	62.77	8.84	6.35	1.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	67.25	9.44	2.74	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	65.68	8.33	2.24	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.76	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.00	2.47	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.16	1.75	0.87	0.00
Hepatocyte, donor1	11523-119I2	47.21	3.63	3.63	0.00
Hepatocyte, donor2	11603-120I1	57.10	5.39	1.08	0.00
Hepatocyte, donor3	11684-122I1	42.33	3.68	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.33	5.87	2.61	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.11	8.04	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.23	2.88	2.33	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	4.15	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	29.24	6.50	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	3.97	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	5.54	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	21.42	2.52	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.98	7.75	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	4.83	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	4.89	0.00	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.05	6.72	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	7.23	0.80	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	3.69	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.99	3.30	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	4.53	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	6.46	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	25.41	7.62	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	3.83	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	5.47	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.14	6.43	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.52	2.16	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	12.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	10.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	4.36	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.38	3.75	1.39	1.55
Keratinocyte - epidermal, donor2	11349-117G8	7.03	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	34.27	3.31	3.69	0.85
Keratinocyte - oral, donor1	11251-116E9	43.93	5.90	6.24	1.59
Keratocytes, donor1	11527-119I6	16.50	3.44	0.69	0.00
Keratocytes, donor2	11607-120I5	4.69	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	35.37	6.32	2.17	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	2.20	4.40	6.59
Lens Epithelial Cells, donor1	11529-119I8	11.87	4.31	6.47	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.34	4.84	2.77	0.46
Lens Epithelial Cells, donor3	11690-122I7	17.36	3.83	1.51	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.35	0.95	0.83	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.54	0.84	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.53	1.73	2.52	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.25	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.93	0.43	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.88	1.23	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.28	0.51	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.04	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	1.19	3.16	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	0.97	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	0.74	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.59	1.39	1.74	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.68	1.19	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.46	0.41	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	0.94	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.87	1.28	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.16	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.49	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.06	0.48	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.85	0.81	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.72	0.61	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.08	0.63	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.62	0.90	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.65	0.75	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.77	0.64	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.44	1.45	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.60	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.58	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.21	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.59	1.98	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.77	0.55	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.66	2.25	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.04	3.65	1.83	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.46	0.84	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	0.71	1.78	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	0.47	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.82	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.84	0.98	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.35	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.99	0.62	0.87	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	2.30	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	0.00	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.73	1.69	0.42	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	2.80	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	2.06	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	3.57	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.27	1.81	0.45	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.61	3.49	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.56	3.60	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.50	2.57	0.14	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.32	2.57	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	4.59	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.81	3.06	0.51	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	18.14	2.93	1.60	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.87	3.78	0.94	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	1.84	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	2.45	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.79	4.16	0.83	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.54	2.80	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	2.06	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.29	1.74	1.16	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.14	2.39	0.60	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	14.38	5.53	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.60	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	2.95	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.75	0.77	1.54	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.62	0.00	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	1.64	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	10.85	2.71	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	3.59	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	1.49	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.29	0.37	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	3.02	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	1.71	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.99	2.00	0.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	4.22	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	1.42	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.69	1.37	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	2.68	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	2.22	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	1.16	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.20	0.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.81	0.73	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	6.90	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.35	1.48	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7.54	3.02	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.56	1.80	0.90	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	1.72	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.91	2.67	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	1.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	2.59	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.50	2.63	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	2.24	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.02	3.53	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.20	2.70	1.93	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.67	4.05	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.42	1.44	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	3.18	0.40	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.37	3.04	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	11.02	1.90	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	3.61	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.41	2.85	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	4.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.31	2.57	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	1.41	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	0.00	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.57	0.83	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.18	0.78	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.10	1.67	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.69	1.39	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.90	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	9.70	2.42	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	0.92	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.00	1.78	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	8.55	1.14	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	1.53	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.13	1.64	1.09	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.68	3.12	0.45	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.80	2.86	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	1.33	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	19.83	0.23	5.93	0.23
Macrophage - monocyte derived, donor2	11313-117C8	20.37	2.02	1.65	0.00
Macrophage - monocyte derived, donor3	11389-118C3	21.76	1.97	1.97	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	2.12	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	25.67	3.96	5.86	0.63
Mallassez-derived cells, donor3	11930-125I4	23.77	2.64	4.17	0.42
Mammary Epithelial Cell, donor1	11273-116H4	39.16	6.28	3.39	1.10
Mammary Epithelial Cell, donor2	11350-117G9	41.70	7.82	2.90	1.45
Mammary Epithelial Cell, donor3	11422-118F9	7.23	1.75	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	146.43	2.71	22.37	0.00
Mast cell, donor1	11563-120D6	39.15	2.60	4.43	0.11
Mast cell, donor2	11565-120D8	32.99	3.57	5.05	1.49
Mast cell, donor3	11566-120D9	45.02	5.40	5.40	3.38
Mast cell, donor4	11567-120E1	42.19	4.08	6.56	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	46.02	3.22	3.55	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	57.20	2.92	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	34.99	2.06	2.87	0.00
Mast cell, expanded, donor8	11941-126A6	44.35	5.19	4.85	1.67
Melanocyte - dark, donor1	11502-119F8	26.07	2.49	1.29	0.00
Melanocyte - dark, donor2	11582-120F7	11.42	2.42	1.38	0.69
Melanocyte - dark, donor3	11663-122F7	33.11	3.77	2.90	0.00
Melanocyte - light, donor1	11274-116H5	7.29	1.18	0.71	0.00
Melanocyte - light, donor2	11351-117H1	6.14	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	7.81	2.60	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	25.51	2.92	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	26.89	2.15	1.34	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	34.82	3.48	1.61	0.27
Meningeal Cells, donor1	11493-119E8	20.84	2.98	0.99	0.00
Meningeal Cells, donor2	11573-120E7	13.64	1.32	0.44	0.88
Meningeal Cells, donor3	11654-122E7	40.10	5.38	1.79	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.67	4.85	3.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.40	2.62	1.91	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	16.50	2.87	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.15	2.12	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	3.02	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	2.20	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	3.65	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.23	0.61	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.42	2.91	3.19	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	1.49	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	32.63	4.87	2.37	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	1.19	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.13	3.90	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.33	2.81	3.75	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.14	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	16.18	3.18	2.39	0.80
Mesothelial Cells, donor2	12156-128G5	11.51	2.00	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	15.83	3.25	2.24	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	21.67	1.97	4.19	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.79	0.59	0.59	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	3.46	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.50	2.17	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.59	0.41	3.32	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.02	2.25	1.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	19.08	0.93	2.33	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.85	1.63	2.03	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	0.79	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.20	1.52	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.61	0.64	1.27	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.41	0.89	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	1.68	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.79	1.25	1.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.45	0.71	2.38	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.03	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.58	2.76	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	1.47	1.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.88	2.04	0.82	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	14.37	1.72	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.00	2.67	0.89	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	1.31	0.44	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.12	1.36	1.63	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.59	1.18	0.88	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	0.00	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	0.96	0.00	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	1.60	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.02	1.50	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.01	2.19	1.75	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	4.48	0.64	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.90	1.98	1.98	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	2.78	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.91	3.76	3.08	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	1.31	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	2.49	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.27	2.24	3.09	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.88	1.66	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	1.17	1.75	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.40	3.32	2.11	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	1.25	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	0.92	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	2.28	5.69	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.83	2.35	2.63	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	1.81	2.33	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	3.00	0.86	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.69	2.54	1.27	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.75	4.00	0.80	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.75	0.90	1.80	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.69	1.84	1.55	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.20	2.87	2.23	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	22.11	2.21	3.32	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.61	1.90	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.14	2.27	3.13	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.65	1.72	1.97	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.90	1.96	0.65	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	20.58	2.35	3.82	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.64	2.59	3.46	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	2.47	4.53	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	30.67	3.87	2.38	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.44	0.33	2.63	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	2.10	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.55	1.38	2.57	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	3.73	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.27	1.13	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.04	1.86	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.40	1.13	3.17	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	2.93	2.93	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	3.11	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	0.00	2.14	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	19.40	1.26	0.84	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	2.72	5.45	6.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	0.64	3.18	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	1.62	4.05	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	0.00	9.79	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.47	2.59	3.02	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	21.43	4.70	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.70	5.34	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.45	2.09	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.59	2.47	1.14	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	7.98	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	51.45	3.68	7.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.88	2.51	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.64	4.88	1.16	2.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.59	2.70	1.62	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.65	4.41	1.05	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	22.27	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.31	4.96	2.98	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	3.25	1.08	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.69	3.40	1.36	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.68	3.92	0.82	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.86	4.92	2.92	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	4.77	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.61	4.20	4.20	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	0.98	3.94	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	3.25	0.81	3.25
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.81	3.00	2.29	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	5.06	0.92	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.82	2.89	1.93	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.76	2.07	6.90	4.48
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	58.15	10.11	20.23	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.62	4.46	1.78	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	2.96	1.27	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.67	4.75	3.32	3.09
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.03	3.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	18.06	99.31	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.66	4.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.35	2.71	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	5.16	1.19	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.41	2.27	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.32	2.28	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	21.79	4.79	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	4.52	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	5.29	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	4.65	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	6.94	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.84	2.30	0.77	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.49	3.63	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.32	4.64	0.66	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	4.07	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	25.55	56.20	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	4.88	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.94	6.29	0.63	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.87	2.42	0.61	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	3.16	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	4.53	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	25.29	55.64	5.06
Myoblast, donor1	11241-116D8	16.27	1.86	2.98	0.12
Myoblast, donor2	11322-117D8	26.08	4.03	3.26	0.38
Myoblast, donor3	11398-118D3	23.04	4.37	3.53	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	36.19	5.40	2.19	1.02
Natural Killer Cells, donor1	11230-116C6	61.81	4.61	3.38	5.23
Natural Killer Cells, donor2	11311-117C6	52.77	6.03	4.52	12.67
Natural Killer Cells, donor3	11387-118C1	59.27	5.34	4.42	9.57
Neural stem cells, donor1	11275-116H6	26.86	4.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	25.03	7.70	3.85	0.00
Neurons, donor1	11494-119E9	20.48	1.14	0.00	1.14
Neurons, donor2	11574-120E8	15.41	4.40	0.88	0.00
Neurons, donor3	11655-122E8	23.02	4.11	2.47	0.82
Neutrophils, donor1	11233-116C9	25.98	3.71	0.00	0.00
Neutrophils, donor2	11314-117C9	17.39	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	26.88	5.50	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	22.56	5.22	3.80	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	10.42	0.98	1.30	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	12.63	2.21	1.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	21.47	2.48	1.10	0.69
Olfactory epithelial cells, donor2	11934-125I8	27.50	3.47	4.34	1.59
Olfactory epithelial cells, donor3	11935-125I9	25.08	3.29	1.70	1.48
Olfactory epithelial cells, donor4	11936-126A1	35.36	2.43	2.05	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	27.08	4.21	2.41	3.01
Osteoblast - differentiated, donor1	11276-116H7	12.97	2.77	1.28	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	3.43	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	8.69	3.72	2.48	1.24
Osteoblast, donor1	11277-116H8	3.91	0.98	0.39	0.20
Osteoblast, donor2	11354-117H4	24.58	3.51	1.40	0.00
Osteoblast, donor3	11426-118G4	18.48	3.02	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	32.26	4.97	6.57	1.18
Pericytes, donor1	11491-119E6	4.78	0.45	0.11	0.11
Pericytes, donor2	11571-120E5	5.21	1.13	0.68	0.00
Pericytes, donor3	11652-122E5	4.88	1.83	0.00	0.00
Perineurial Cells, donor1	11499-119F5	22.15	5.65	3.73	0.11
Perineurial Cells, donor2	11579-120F4	20.06	2.94	2.12	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.02	7.01	1.91	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	50.93	4.90	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	53.71	5.69	2.33	2.20
Placental Epithelial Cells, donor1	11278-116H9	6.94	2.15	0.00	0.72
Placental Epithelial Cells, donor2	11355-117H5	8.87	1.11	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	7.66	2.16	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	1.27	3.16	0.95
Preadipocyte - breast, donor1	11467-119B9	18.95	2.81	3.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.10	3.65	2.09	0.78
Preadipocyte - breast, donor2	11328-117E5	21.61	3.15	2.25	0.45
Preadipocyte - omental, donor1	11468-119C1	21.10	2.77	2.56	0.85
Preadipocyte - omental, donor2	11329-117E6	18.77	4.80	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	23.35	3.44	2.72	1.58
Preadipocyte - perirenal, donor1	11469-119C2	0.98	0.98	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	14.43	1.54	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	41.61	6.20	1.24	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	24.52	3.58	1.19	0.17
Preadipocyte - visceral, donor1	11280-116I2	38.56	6.15	3.35	0.47
Preadipocyte - visceral, donor2	11357-117H7	35.43	5.98	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	26.85	2.82	1.57	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	33.49	5.28	1.96	0.91
Prostate Epithelial Cells, donor2	11331-117E8	11.24	2.03	0.95	0.54
Prostate Epithelial Cells, donor3	11404-118D9	28.29	6.92	3.12	0.55
Prostate Stromal Cells, donor1	11254-116F3	32.12	3.87	2.05	0.57
Prostate Stromal Cells, donor2	11332-117E9	45.18	7.17	4.30	1.61
Prostate Stromal Cells, donor3	11405-118E1	38.69	4.90	3.55	2.71
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	1.46	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.77	5.75	1.73	0.35
Renal Epithelial Cells, donor1	11517-119H5	8.12	1.01	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	1.42	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	30.70	5.50	1.59	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.84	1.21	0.40	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.76	1.78	2.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.02	0.66	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	6.27	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.69	1.61	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	1.74	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.96	3.11	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	1.14	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.57	7.78	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	45.44	7.08	2.27	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	48.24	6.25	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	45.68	7.71	11.01	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	71.93	10.44	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	60.07	6.50	1.30	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	57.00	6.55	2.48	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.33	6.02	1.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	60.04	7.19	2.85	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	58.97	7.11	3.03	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.25	6.70	3.47	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	49.42	5.07	2.05	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	58.39	6.96	2.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	69.71	7.88	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	48.63	5.74	1.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.65	5.69	2.15	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	49.56	4.20	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	51.62	4.40	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	54.41	7.64	2.33	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	71.97	9.21	2.44	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	64.89	6.24	0.93	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	58.70	9.25	3.41	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.38	5.54	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.53	5.45	2.03	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	60.83	6.45	3.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.11	7.18	1.71	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.14	5.29	1.09	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	53.96	6.87	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.01	7.52	2.15	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	54.25	6.13	3.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	52.38	7.54	3.97	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.21	9.35	2.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.07	6.22	1.24	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	56.41	6.64	2.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.25	6.68	2.30	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	57.60	6.59	2.02	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	60.62	7.49	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	59.77	8.48	1.93	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	59.32	4.30	1.38	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.16	7.82	1.23	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	62.55	6.73	2.30	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	55.05	4.94	1.02	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	54.74	7.84	4.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	66.90	9.33	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	53.79	6.36	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	52.38	8.81	2.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	76.79	9.27	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	44.17	5.27	1.13	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	64.63	4.54	3.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	58.02	7.86	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.81	4.04	0.98	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	105.96	13.97	2.91	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	44.42	4.26	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	51.84	1.81	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.69	5.43	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.71	8.99	1.80	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	40.50	5.20	0.83	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	46.53	6.40	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.34	6.01	1.20	0.60
Schwann Cells, donor1	11498-119F4	5.45	0.94	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	18.40	2.41	2.41	0.00
Sebocyte, donor1	11220-116B5	18.62	2.19	1.10	0.00
Sebocyte, donor2	11301-117B5	14.71	0.46	0.46	1.84
Sebocyte, donor3	11378-118B1	8.66	1.24	0.00	0.82
Sertoli Cells, donor1	11255-116F4	19.88	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	16.95	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	23.23	4.93	0.97	0.18
Skeletal Muscle Cells, donor2	11358-117H8	1.45	0.72	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	11.70	1.67	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	24.19	3.77	0.63	0.47
Skeletal Muscle Cells, donor5	11455-119A6	22.74	3.57	0.59	0.30
Skeletal Muscle Cells, donor6	11459-119B1	31.86	2.77	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	24.19	3.91	4.79	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.54	4.14	1.85	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.36	4.96	1.59	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.79	4.63	1.52	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.39	1.79	0.28	0.55
Skin - palm, donor1	10286-104F7	13.43	2.69	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.52	2.02	2.31	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	2.45	6.54	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.13	1.04	0.78	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	25.86	4.03	1.95	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	36.71	4.08	1.97	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	37.64	3.81	5.29	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	42.65	5.55	1.42	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.13	1.85	1.54	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.23	2.00	1.78	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	1.76	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.63	1.33	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.12	0.39	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.00	1.55	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	7.01	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.12	1.60	0.80	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.97	3.99	1.99	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.49	1.54	1.15	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.81	3.91	2.60	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.15	2.95	2.95	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.37	2.28	1.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.65	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	3.96	2.44	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.34	0.51	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.30	4.13	1.47	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.60	3.66	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.67	4.62	1.57	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.81	1.24	0.31	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.47	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.51	2.05	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	34.08	5.65	4.00	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.93	3.93	3.72	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.02	3.64	1.37	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.88	7.68	1.85	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	55.13	7.86	3.60	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.19	6.76	2.00	2.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.65	2.03	3.55	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.86	2.11	2.86	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	1.50	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.63	1.86	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	3.03	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.09	1.57	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.31	0.88	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.07	5.66	3.00	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	3.27	1.87	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.19	1.44	0.43	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.96	0.51	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.64	0.75	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.34	3.49	2.79	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	21.03	4.86	1.51	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	1.90	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.89	0.73	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	37.34	3.98	2.87	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.21	1.46	2.34	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.93	3.11	1.75	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.07	3.44	2.91	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.37	2.60	7.44	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	2.52	5.75	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.55	3.41	4.54	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.48	2.76	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	15.49	3.56	6.35	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	26.75	6.79	4.39	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	4.60	3.34	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	16.04	5.04	2.75	0.46
Synoviocyte, donor1	11291-117A4	18.01	2.02	1.85	0.34
Synoviocyte, donor2	11368-117I9	14.42	1.68	2.18	0.34
Synoviocyte, donor3	11440-118H9	16.53	2.01	4.02	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	8.93	2.50	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	10.65	1.62	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	15.99	2.22	0.93	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	52.41	7.14	2.46	1.35
Urethra, donor2	10319-105A4	26.98	3.60	3.60	0.00
Urothelial Cells, donor1	11520-119H8	4.52	0.00	1.06	0.53
Urothelial Cells, donor2	11600-120H7	5.61	0.80	0.00	0.40
Urothelial Cells, donor3	11681-122H7	7.11	0.23	0.23	0.23
Urothelial cells, donor0	11216-116B1	33.21	4.46	3.34	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.03	4.45	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	0.00	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.96	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.58	2.07	2.07	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.38	1.74	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	31.20	5.51	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	0.91	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	27.02	4.56	1.60	1.60
Wilms' tumor cell line:HFWT	10597-108E3	28.16	2.64	0.88	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	61.17	11.17	4.19	0.56
achilles tendon, donor2	10292-104G4	31.00	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.50	4.08	3.06	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	51.54	4.88	5.11	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	59.59	9.73	1.07	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	53.33	7.07	3.81	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	41.60	3.94	4.22	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	38.49	5.50	3.60	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.47	6.26	4.08	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	47.15	5.29	4.85	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	52.27	3.27	6.53	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	41.94	2.33	3.49	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	71.39	5.70	3.68	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	11.70	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.55	4.42	5.34	2.56
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	62.65	5.18	6.73	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	64.88	4.68	6.43	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	71.11	10.69	5.11	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.84	3.29	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	81.65	7.06	2.15	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	78.51	5.12	5.12	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	84.01	7.28	9.40	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	106.15	8.91	7.22	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	49.23	5.79	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	80.05	8.67	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	5.57	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	62.15	9.04	2.26	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	54.95	6.54	1.74	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	1.87	9.37	5.62
adenocarcinoma cell line:IM95m	10796-110I4	33.91	4.95	3.06	1.41
adipose tissue, adult, pool1	10010-101C1	34.44	2.79	1.55	0.00
adipose, donor1	10184-103D4	28.15	4.10	4.69	0.00
adipose, donor2	10185-103D5	19.06	6.89	0.81	0.41
adipose, donor3	10186-103D6	22.33	4.08	2.72	1.09
adipose, donor4	10187-103D7	28.60	6.93	3.47	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.67	9.94	3.00	0.16
adrenal gland, adult, pool1	10081-102A9	58.20	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.61	6.14	1.60	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	66.82	5.36	3.22	0.36
amniotic membrane cells, donor1	12235-129G3	32.92	7.42	2.78	1.39
amniotic membrane cells, donor2	12236-129G4	28.40	5.75	2.37	1.01
amniotic membrane cells, donor3	12237-129G5	24.45	2.95	3.54	1.47
amygdala - adult, donor10196	10167-103B5	50.99	7.11	5.93	1.19
amygdala, adult, donor10252	10151-102I7	44.81	6.29	3.24	0.20
amygdala, newborn, donor10223	10360-105E9	16.46	4.52	0.00	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	28.78	3.69	1.02	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	34.20	5.96	1.76	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	40.75	13.36	1.00	0.67
aorta, adult, pool1	10052-101G7	29.62	2.55	1.96	0.78
appendix, adult	10189-103D9	43.08	2.33	2.72	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	26.48	3.78	4.13	0.00
artery, adult	10190-103E1	54.35	9.51	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	39.84	6.95	3.04	0.72
b cell line:RPMI1788	10427-106D4	49.96	7.44	3.72	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.92	2.50	2.77	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	52.30	5.85	2.08	1.89
bile duct carcinoma cell line:TFK-1	10496-107C1	45.36	6.36	3.51	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	26.84	3.36	1.68	1.68
bladder, adult, pool1	10011-101C2	54.43	8.04	2.82	0.65
blood, adult, pool1	10053-101G8	13.29	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	2.57	4.28	0.00
bone marrow, adult	10192-103E3	45.21	8.10	2.02	0.67
brain, adult, donor1	10084-102B3	19.48	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	27.17	4.01	1.45	0.11
brain, fetal, pool1	10085-102B4	13.36	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	60.79	9.25	2.64	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	62.91	11.11	4.87	2.37
breast, adult, donor1	10080-102A8	41.67	5.68	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	80.16	6.99	6.10	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.25	5.88	2.16	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	55.48	10.82	10.59	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	52.05	4.60	4.60	0.97
carcinoid cell line:NCI-H1770	10703-109H1	20.22	5.64	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.27	3.61	0.55	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	22.82	2.54	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.06	9.05	3.99	0.53
caudate nucleus - adult, donor10196	10177-103C6	36.84	12.66	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	50.37	7.53	1.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	35.91	4.58	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	16.11	4.39	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	90.31	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	77.93	11.74	2.78	0.00
cerebellum, adult, pool1	10083-102B2	28.63	3.45	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	34.04	9.13	1.66	0.00
cerebral meninges, adult	10188-103D8	37.82	5.80	1.26	0.76
cerebrospinal fluid, donor2	10294-104G6	15.35	4.39	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	98.35	11.22	3.74	0.58
cervical cancer cell line:ME-180	10553-107I4	47.56	5.63	1.49	0.33
cervix, adult, pool1	10013-101C4	60.16	11.86	3.57	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.86	7.52	2.23	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	3.92	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	53.31	11.93	2.24	0.87
choriocarcinoma cell line:SCH	10785-110H2	20.58	6.16	2.59	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	24.90	6.88	0.47	1.42
chorionic membrane cells, donor1	12238-129G6	19.09	6.84	1.42	3.42
chorionic membrane cells, donor2	12239-129G7	24.66	4.28	1.79	1.29
chorionic membrane cells, donor3	12240-129G8	21.43	3.85	2.75	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	39.19	2.69	3.84	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.67	2.75	1.69	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	74.22	14.64	3.08	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	96.75	14.51	0.73	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	101.19	14.46	2.85	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	79.80	11.19	4.12	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.26	6.26	2.87	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	24.92	3.89	4.34	0.46
clear cell carcinoma cell line:TEN	10636-108I6	22.21	3.30	0.87	0.87
colon carcinoma cell line:CACO-2	10513-107D9	32.58	7.14	1.65	1.46
colon carcinoma cell line:COLO-320	10420-106C6	44.47	6.84	1.14	0.38
colon, adult, donor1	10082-102B1	28.56	3.57	1.19	0.00
colon, adult, pool1	10014-101C5	39.60	4.47	1.65	0.71
colon, fetal, donor1	10070-101I7	51.91	8.65	2.47	0.62
common myeloid progenitor CMP, donor1	12130-128D6	220.01	18.33	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	52.69	5.95	2.12	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	42.56	3.62	2.26	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	39.77	3.81	3.53	0.99
corpus callosum, adult, pool1	10042-101F6	29.08	4.42	1.44	0.22
cruciate ligament, donor2	10295-104G7	25.12	2.43	1.62	1.62
diaphragm, fetal, donor1	10069-101I6	60.99	8.03	0.80	0.00
diencephalon, adult	10193-103E4	28.80	3.12	2.88	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	41.33	4.36	5.05	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	121.81	16.16	2.05	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.13	6.26	3.61	2.17
ductus deferens, adult	10196-103E7	41.36	2.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	4.41	4.41	0.00
dura mater, adult, donor1	10041-101F5	23.45	4.38	2.31	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.96	20.43	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	49.72	9.60	0.86	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	21.58	3.08	1.85	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	26.94	2.72	3.94	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	34.89	4.32	0.93	3.09
embryonic pancreas cell line:2C6	10603-108E9	19.70	1.31	5.25	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	32.85	4.69	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	35.34	7.25	2.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	20.26	3.22	3.06	1.13
epidermoid carcinoma cell line:A431	10426-106D3	31.46	3.56	1.33	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	99.10	14.63	4.62	3.19
epididymis, adult	10197-103E8	28.68	3.56	1.67	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.77	4.26	4.44	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.54	3.93	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	71.68	9.57	3.41	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	80.70	9.45	4.04	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	73.27	10.31	5.27	1.68
esophagus, adult, pool1	10015-101C6	46.40	5.52	2.87	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	41.45	10.02	3.01	1.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	7.24	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	0.00	1.49	1.49
eye - muscle superior, donor2	10297-104G9	24.08	2.29	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	20.40	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	26.69	6.10	2.80	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	27.57	3.33	2.44	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	43.21	4.75	3.09	0.71
frontal lobe, adult, pool1	10040-101F4	37.81	5.54	2.63	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.54	8.41	3.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	80.74	8.05	11.98	0.46
gall bladder, adult	10198-103E9	22.94	2.90	1.45	0.72
gamma delta positive T cells, donor1	11937-126A2	37.58	3.76	3.76	1.61
gamma delta positive T cells, donor2	11938-126A3	46.31	5.60	3.36	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	54.71	6.97	3.17	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	55.32	5.80	8.51	2.32
gastric cancer cell line:AZ521	10549-107H9	30.66	7.05	4.26	1.15
gastric cancer cell line:GSS	10560-108A2	54.00	10.07	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	51.40	7.31	2.51	0.46
giant cell carcinoma cell line:LU65	10487-107B1	19.51	4.02	0.34	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	47.59	8.82	1.68	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.91	4.49	2.00	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.88	4.86	1.90	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.97	4.35	2.53	0.28
glioblastoma cell line:T98G	10485-107A8	71.74	7.84	2.21	2.76
glioma cell line:GI-1	10413-106B8	46.27	4.39	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	51.02	6.56	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	70.30	10.01	2.44	0.73
globus pallidus, adult, donor10258	10367-105F7	20.54	5.48	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	22.92	4.80	2.13	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	185.98	24.47	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	15.36	2.56	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	28.01	6.89	1.84	1.38
hIPS +CCl2, biol_rep2	14384-156C1	29.26	7.32	3.20	0.46
hIPS +CCl2, biol_rep3	14385-156C2	27.70	6.44	1.93	0.00
hIPS, biol_rep1	14380-156B6	20.12	4.31	1.44	0.00
hIPS, biol_rep2	14381-156B7	25.38	7.54	0.69	0.00
hIPS, biol_rep3	14382-156B8	20.97	4.41	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	30.17	7.76	4.60	4.31
heart - mitral valve, adult	10205-103F7	37.97	6.58	2.69	7.77
heart - pulmonic valve, adult	10206-103F8	51.25	8.37	3.40	1.57
heart - tricuspid valve, adult	10207-103F9	55.79	5.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	33.67	5.71	4.08	0.82
heart, adult, diseased, donor1	10051-101G6	21.29	3.41	1.28	1.70
heart, adult, pool1	10016-101C7	61.17	13.11	0.92	1.61
heart, fetal, pool1	10046-101G1	66.54	22.49	3.90	4.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	31.78	3.39	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	0.00	2.38	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	43.65	9.50	1.22	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.39	12.14	2.67	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	47.39	9.60	2.63	2.73
hepatoma cell line:Li-7	10484-107A7	40.15	6.67	1.45	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	40.20	6.43	1.61	1.01
hippocampus - adult, donor10196	10169-103B7	36.91	1.89	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	45.92	7.76	1.84	0.00
hippocampus, adult, donor10258	10374-105G5	32.86	5.98	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	15.16	4.23	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	54.32	12.21	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	42.22	11.98	2.75	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.21	7.11	1.78	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	20.86	6.20	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	7.23	2.58	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.12	4.93	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.02	4.09	0.00	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	20.68	3.88	0.43	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	23.36	4.17	2.09	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.21	4.50	0.95	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.88	4.34	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.93	3.37	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	33.49	9.39	2.66	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	34.39	10.32	3.44	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	39.27	6.98	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.68	5.15	0.76	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.91	8.29	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.49	4.00	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	18.27	6.41	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.28	10.46	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.41	8.14	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.39	3.27	0.82	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.64	3.48	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	16.44	4.18	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	40.83	8.68	2.96	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.66	7.99	2.00	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.06	8.17	4.49	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	21.83	4.93	2.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	4.43	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	21.49	5.75	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	3.62	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	18.60	5.31	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	12.83	4.87	0.51	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	17.64	3.32	1.53	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	4.54	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.79	5.04	1.01	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	38.16	9.90	2.66	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	35.21	6.24	3.12	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	40.00	6.83	1.95	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	20.48	6.11	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	16.27	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	15.89	4.96	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.34	5.47	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.39	3.62	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.74	6.05	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.42	5.96	1.35	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.20	5.39	0.81	1.08
immature langerhans cells, donor1	11904-125F5	50.85	16.95	2.42	4.84
immature langerhans cells, donor2	11905-125F6	30.89	7.92	5.54	3.96
insula, adult, pool1	10039-101F3	26.31	2.84	1.51	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	49.42	6.50	3.58	1.63
kidney, adult, pool1	10017-101C8	50.16	5.91	1.30	0.90
kidney, fetal, pool1	10045-101F9	24.47	5.80	0.64	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.90	13.21	7.81	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.82	1.38	0.41	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	81.29	8.99	2.57	2.57
left atrium, adult, donor1	10079-102A7	40.86	3.27	1.63	0.00
left ventricle, adult, donor1	10078-102A6	35.90	7.58	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	30.10	2.74	1.64	0.82
leiomyoma cell line:10964C	10569-108B2	14.37	2.16	1.08	1.80
leiomyoma cell line:15242A	10570-108B3	14.13	4.89	1.09	1.09
leiomyoma cell line:15425	10571-108B4	10.68	2.43	2.91	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	6.27	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	35.65	4.96	3.19	1.18
liposarcoma cell line:KMLS-1	10782-110G8	12.34	2.19	1.72	0.62
liposarcoma cell line:SW 872	10726-110A6	51.05	5.97	2.68	0.24
liver, adult, pool1	10018-101C9	38.08	4.54	1.13	1.13
liver, fetal, pool1	10086-102B5	12.23	7.53	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	55.41	10.50	2.62	0.15
locus coeruleus, adult, donor10252	10165-103B3	46.51	6.09	2.40	0.18
locus coeruleus, adult, donor10258	10375-105G6	15.80	2.26	1.97	0.85
locus coeruleus, newborn, donor10223	10362-105F2	15.56	5.89	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	15.78	4.43	0.97	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	77.21	10.34	11.03	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.51	5.14	2.77	1.19
lung, adult, pool1	10019-101D1	36.38	6.02	1.54	0.59
lung, fetal, donor1	10068-101I5	58.51	14.27	3.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	30.70	4.58	2.75	0.46
lymph node, adult, donor1	10077-102A5	32.66	4.26	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	67.51	12.93	1.97	2.85
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	39.84	5.13	3.47	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	58.62	5.10	1.70	0.85
mature adipocyte, donor1	12231-129F8	55.94	4.00	0.89	0.44
mature adipocyte, donor2	12232-129F9	54.37	5.60	1.87	0.62
mature adipocyte, donor3	12233-129G1	36.98	3.32	2.13	0.47
mature adipocyte, donor4	12234-129G2	52.12	5.26	3.16	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	152.01	19.30	9.53	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	49.63	3.38	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	54.62	7.17	2.57	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	35.58	4.13	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	2.99	3.41	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	53.16	6.24	7.09	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	56.88	5.09	2.33	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	0.00	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	10.41	1.08	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	37.64	1.95	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	48.92	7.74	2.94	0.15
medulla oblongata, adult, pool1	10038-101F2	23.18	4.82	1.80	0.33
medulla oblongata, newborn, donor10223	10361-105F1	26.39	3.82	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	63.10	13.06	3.10	0.22
medulloblastoma cell line:ONS-76	10759-110E3	46.22	3.91	0.86	0.73
melanoma cell line:COLO 679	10514-107E1	21.27	3.31	0.86	0.29
melanoma cell line:G-361	10465-106H6	19.00	2.99	1.63	0.00
meningioma cell line:HKBMM	10691-109F7	17.19	2.17	1.27	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	81.95	11.46	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	55.73	8.30	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.49	1.07	2.45	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.91	1.45	2.36	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	0.83	2.90	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.54	0.98	4.50	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.98	2.70	2.89	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	0.69	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.64	1.89	3.26	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.26	2.42	3.57	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.38	1.86	1.99	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.02	1.62	2.43	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.35	3.41	1.42	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	2.31	0.99	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	14.81	1.38	1.11	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.64	1.05	3.49	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.11	3.06	2.04	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	2.52	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.24	1.03	1.86	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.12	3.42	1.14	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	25.59	4.20	3.36	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.45	1.79	1.20	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.00	1.84	1.58	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.41	2.58	1.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.31	2.00	2.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.73	2.95	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	1.37	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.37	1.28	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.04	1.05	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.94	0.92	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.00	0.94	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.54	1.69	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	1.96	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	1.39	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.00	3.17	4.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.62	2.01	1.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.54	2.88	0.96	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	4.40	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.78	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	2.46	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	2.15	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.29	1.95	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	4.26	3.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	1.64	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.55	1.55	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	2.37	2.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	1.27	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.62	1.72	2.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	4.30	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	1.22	2.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	1.59	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	0.59	3.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.22	1.56	2.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	2.37	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	0.69	4.13	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.36	4.45	3.96	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.27	4.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.90	6.45	2.01	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	1.82	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	4.94	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.29	1.79	1.39	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.71	1.95	2.27	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	2.04	6.11	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	2.32	3.87	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	62.84	8.50	5.67	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.79	5.56	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.11	2.47	2.77	0.41
mesothelioma cell line:Mero-25	10850-111F4	26.33	5.45	1.59	0.45
mesothelioma cell line:Mero-41	10851-111F5	37.16	5.13	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	29.89	3.32	2.66	0.89
mesothelioma cell line:Mero-82	10853-111F7	40.73	6.04	4.47	1.58
mesothelioma cell line:Mero-83	10854-111F8	24.85	3.40	4.09	1.02
mesothelioma cell line:Mero-84	10855-111F9	23.00	5.06	1.77	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.13	5.18	3.52	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	52.68	4.64	4.14	1.16
mesothelioma cell line:NCI-H226	10846-111E9	23.53	3.44	1.27	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	38.95	3.59	1.88	0.85
mesothelioma cell line:NCI-H28	10845-111E8	18.83	5.09	3.56	0.25
mesothelioma cell line:No36	10857-111G2	33.27	3.91	2.61	0.33
mesothelioma cell line:ONE58	10858-111G3	28.45	3.52	1.35	1.08
migratory langerhans cells, donor1	11901-125F2	66.02	10.56	5.57	2.49
migratory langerhans cells, donor2	11902-125F3	65.09	4.76	5.25	2.20
migratory langerhans cells, donor3	11903-125F4	77.89	7.54	6.46	5.20
mixed mullerian tumor cell line:HTMMT	10689-109F5	46.69	8.81	1.63	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.85	6.57	0.85	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	109.19	11.29	6.68	4.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.54	3.23	1.90	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	69.67	6.47	2.40	0.74
myeloma cell line:PCM6	10474-106I6	24.31	4.15	3.56	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	27.39	4.06	2.54	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.22	3.92	2.75	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	25.96	5.46	0.56	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.37	5.07	1.10	0.29
nasal epithelial cells, donor2	12227-129F4	32.02	3.86	2.21	1.66
neuroblastoma cell line:CHP-134	10508-107D4	56.36	12.19	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	35.55	7.67	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	19.40	1.90	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	53.11	7.27	3.17	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.40	3.56	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.90	3.80	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	18.11	2.82	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	24.79	2.54	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.56	2.66	1.06	0.53
neutrophil PMN, donor1	12133-128D9	59.50	29.75	14.87	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	106.38	9.30	2.03	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	18.92	2.89	1.60	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.95	5.26	1.31	2.63
nucleus accumbens, adult, pool1	10037-101F1	27.75	5.62	2.16	0.00
occipital cortex - adult, donor10196	10172-103C1	67.99	12.36	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	55.82	5.64	2.42	0.27
occipital cortex, newborn, donor10223	10355-105E4	20.38	1.46	1.09	1.09
occipital lobe, adult, donor1	10076-102A4	28.60	2.89	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	25.32	6.01	0.00	0.00
occipital pole, adult, pool1	10036-101E9	14.90	2.05	0.47	0.08
olfactory region, adult	10195-103E6	29.80	4.78	3.82	0.38
optic nerve, donor1	10277-104E7	68.04	12.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.82	6.38	4.56	2.73
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	75.70	9.07	2.20	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	47.92	4.06	4.06	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	37.66	3.81	3.12	2.77
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	2.35	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	50.45	1.87	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	32.02	6.36	3.82	1.06
ovary, adult, pool1	10020-101D2	30.31	8.47	1.05	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.78	6.60	1.47	1.10
pancreas, adult, donor1	10049-101G4	40.45	0.94	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	37.46	6.71	2.52	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	54.68	4.77	5.79	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	32.45	6.46	1.82	5.96
paracentral gyrus, adult, pool1	10035-101E8	28.55	4.39	2.38	0.55
parietal cortex, adult, donor10258	10373-105G4	20.55	4.40	5.14	0.00
parietal lobe - adult, donor10196	10171-103B9	44.20	7.52	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	57.01	5.99	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	28.37	4.23	1.23	0.62
parietal lobe, fetal, donor1	10072-101I9	26.19	10.67	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	19.44	6.36	0.75	2.24
parotid gland, adult	10199-103F1	42.55	5.55	0.62	0.00
penis, adult	10200-103F2	29.00	3.22	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	13.02	4.83	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	52.60	8.89	6.85	1.02
pineal gland - adult, donor10196	10179-103C8	33.54	9.03	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	56.26	7.70	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	26.96	6.27	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	49.58	13.15	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	87.56	21.37	4.17	0.00
pituitary gland, adult, donor10258	10378-105G9	40.01	7.66	4.26	0.85
placenta, adult, pool1	10021-101D3	40.53	9.78	1.83	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	43.83	6.36	2.25	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.17	2.33	1.56	0.78
pons, adult, pool1	10033-101E6	31.24	5.51	4.05	0.60
postcentral gyrus, adult, pool1	10032-101E5	18.48	2.70	1.05	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	150.58	12.55	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	49.96	6.41	6.26	2.04
prostate cancer cell line:PC-3	10439-106E7	37.93	6.72	3.63	0.73
prostate, adult, pool1	10022-101D4	41.72	6.89	2.27	0.54
putamen, adult, donor10196	10176-103C5	37.77	11.09	4.01	0.24
putamen, adult, donor10252	10152-102I8	49.02	9.80	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	5.46	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	20.05	5.32	3.38	0.00
putamen, newborn, donor10223	10365-105F5	16.49	6.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	31.71	6.69	2.62	5.24
rectum, fetal, donor1	10067-101I4	41.73	2.78	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	23.74	5.30	2.76	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	22.78	3.31	2.49	0.83
retina, adult, pool1	10030-101E3	22.17	3.88	1.39	0.20
retinoblastoma cell line:Y79	10475-106I7	44.43	8.05	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.24	5.66	1.84	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.81	7.03	0.84	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	7.58	5.30	2.27
salivary acinar cells, donor1	11771-123I7	14.73	1.62	4.05	4.05
salivary acinar cells, donor2	11772-123I8	22.03	3.03	4.41	2.07
salivary acinar cells, donor3	11773-123I9	17.88	3.31	1.32	3.97
salivary gland, adult, pool1	10093-102C3	20.59	3.43	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	34.99	4.72	2.70	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.27	4.47	4.35	1.06
seminal vesicle, adult	10201-103F3	34.39	4.23	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.38	3.64	3.40	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.89	4.03	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	40.14	6.02	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.70	5.78	2.82	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	32.94	3.09	0.44	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.32	3.35	2.71	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	2.84	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	75.20	14.15	1.20	1.80
skeletal muscle, fetal, donor1	10066-101I3	23.12	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.94	5.05	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	136.41	16.68	3.34	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	85.74	14.18	6.62	5.99
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.36	9.44	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	88.51	14.83	5.44	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.79	10.46	0.97	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	38.79	4.58	1.09	0.65
small intestine, adult, pool1	10024-101D6	43.72	5.14	1.67	0.48
small intestine, fetal, donor1	10064-101I1	26.78	5.90	2.21	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	55.39	2.05	3.59	0.51
smooth muscle, adult, pool1	10048-101G3	48.85	6.98	3.36	0.52
somatostatinoma cell line:QGP-1	10781-110G7	30.29	4.56	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	44.05	6.19	1.84	0.46
spinal cord, adult, donor10252	10159-103A6	45.74	9.07	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	20.75	4.84	5.53	0.69
spinal cord, fetal, donor1	10056-101H2	17.08	4.88	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	38.11	8.73	1.84	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.53	3.29	1.64	1.05
spleen, adult, pool1	10025-101D7	33.04	3.08	1.54	0.33
spleen, fetal, pool1	10044-101F8	16.37	2.86	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	27.53	5.90	3.62	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	31.33	7.03	1.71	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	49.62	8.74	8.04	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	41.05	7.04	1.95	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.71	7.54	2.70	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	40.24	5.93	3.81	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.19	5.50	2.54	2.12
stomach, fetal, donor1	10062-101H8	27.77	7.48	3.20	1.07
submaxillary gland, adult	10202-103F4	34.75	3.99	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	53.17	5.61	2.28	0.42
substantia nigra, adult, donor10258	10371-105G2	40.86	4.66	4.66	0.00
substantia nigra, newborn, donor10223	10358-105E7	23.32	2.12	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.31	8.02	5.96	0.46
temporal lobe, adult, pool1	10031-101E4	16.53	2.80	0.51	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	25.64	8.55	2.85	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	20.66	7.47	0.44	0.00
tenocyte, donor1	11763-123H8	27.93	4.19	3.49	0.00
tenocyte, donor2	11765-123I1	26.32	1.91	3.05	1.14
tenocyte, donor3	11768-123I4	24.46	0.74	6.30	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	51.84	9.18	3.74	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	50.71	9.87	1.39	2.62
teratocarcinoma cell line:PA-1	10807-111A6	57.81	10.54	2.01	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	51.67	9.39	3.30	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	41.98	6.81	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	47.88	4.25	2.18	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	67.42	16.29	7.82	0.65
testis, adult, pool1	10026-101D8	70.76	23.84	2.25	0.43
testis, adult, pool2	10096-102C6	89.77	38.79	12.18	0.45
thalamus - adult, donor10196	10168-103B6	54.10	6.62	2.21	0.00
thalamus, adult, donor10252	10154-103A1	58.92	7.50	1.72	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	3.08	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.06	2.80	1.98	0.49
thalamus, newborn, donor10223	10366-105F6	13.81	2.88	2.30	0.58
throat, adult	10209-103G2	28.96	2.50	2.75	0.75
throat, fetal, donor1	10061-101H7	43.88	5.48	2.44	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	40.34	5.37	0.79	0.40
thymus, adult, pool1	10027-101D9	46.73	6.76	1.79	0.50
thymus, fetal, pool1	10043-101F7	39.38	4.57	1.25	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.81	4.52	0.93	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	45.96	5.17	1.96	0.70
thyroid, adult, pool1	10028-101E1	45.91	9.61	0.93	0.09
thyroid, fetal, donor1	10060-101H6	41.40	7.91	3.43	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	3.08	0.00	0.00
tongue, adult	10203-103F5	42.10	4.19	3.72	0.00
tongue, fetal, donor1	10059-101H5	50.44	10.25	2.76	0.00
tonsil, adult, pool1	10047-101G2	20.74	2.70	0.50	0.40
trachea, adult, pool1	10029-101E2	37.14	3.93	2.13	0.65
trachea, fetal, donor1	10058-101H4	36.16	5.39	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	51.02	4.96	4.25	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	47.52	5.17	1.11	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	65.03	8.93	4.86	2.35
tridermal teratoma cell line:HGRT	10694-109G1	9.51	5.71	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.46	3.98	2.29	2.20
umbilical cord, fetal, donor1	10057-101H3	25.04	6.26	4.17	2.09
uterus, adult, pool1	10100-102D1	37.03	10.92	2.56	0.17
uterus, fetal, donor1	10055-101H1	59.38	10.24	2.56	1.02
vagina, adult	10204-103F6	55.57	10.34	0.00	0.00
vein, adult	10191-103E2	30.03	3.95	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.63	3.47	3.20	0.00